Package 0071-0369-32

{"route": ["ORAL"], "spl_id": "3696853c-9eef-4f2f-8b97-e0df56431698", "openfda": {"upc": ["0300710369245"], "unii": ["4182431BJH"], "rxcui": ["855671", "855673", "855869", "855871"], "spl_set_id": ["8848de76-8d74-4620-bcc7-a86a596e5dd9"], "manufacturer_name": ["Parke-Davis Div of Pfizer Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1000 CAPSULE in 1 BOTTLE (0071-0369-32)", "package_ndc": "0071-0369-32", "marketing_end_date": "20260331", "marketing_start_date": "19760827"}], "brand_name": "Dilantin", "product_id": "0071-0369_3696853c-9eef-4f2f-8b97-e0df56431698", "dosage_form": "CAPSULE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 2C8 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2D6 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "0071-0369", "generic_name": "Extended Phenytoin Sodium", "labeler_name": "Parke-Davis Div of Pfizer Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Dilantin", "active_ingredients": [{"name": "PHENYTOIN SODIUM", "strength": "100 mg/1"}], "application_number": "ANDA084349", "marketing_category": "ANDA", "marketing_end_date": "20260331", "marketing_start_date": "19760827"}